Milnacipran: A serotonin and norepinephrine reuptake inhibitor for the management of fibromyalgia syndrome - - ModernMedicine

Links shared publicly online about this topic.

1,927
total visits

Milnacipran: A serotonin and norepinephrine reuptake inhibitor for the management of fibromyalgia syndrome - - ModernMedicine

Milnacipran was recently approved by FDA for the management of fibromyalgia syndrome. Clinical trials have demonstrated that this agent may be a reasonable alternative or adjunct therapy for patients with fibromyalgia syndrome who are unable to tolerate first-line tricyclic antidepressant therapy.

View full resource at modernmedicine.com

Tags: Antidepressant, Fibromyalgia, Fibromyalgia Medication, Neuropathic Pain Medication, Disease and Condition, Clinical Trial, FDA, Savella